Microbial proteins and cellular structures

Microbial proteins and cellular structures represent a broad category of molecular targets found in bacteria, viruses, fungi, and parasites that are essential for their survival, replication, or pathogenicity. These targets include structural elements like the bacterial peptidoglycan cell wall and fungal ergosterol, as well as functional machinery such as the 30S and 50S ribosomal subunits and DNA gyrase [1][2]. In clinical medicine, these structures are the focus of antimicrobial therapy, where drugs are designed to exploit biochemical differences between microbial and human cells to achieve selective toxicity [3]. For instance, beta-lactam antibiotics interfere with cell wall cross-linking, while fluoroquinolones target enzymes involved in DNA supercoiling [4]. Because this term encompasses thousands of distinct proteins and structures across diverse taxa, it is considered a collective category rather than a specific therapeutic target. The ongoing evolution of these microbial components is the primary driver of antimicrobial resistance, necessitating the continuous discovery of novel targets within this group [5]. Sources: [1] StatPearls (https://www.ncbi.nlm.nih.gov/books/NBK535444/); [2] Nature Reviews Microbiology (https://www.nature.com/articles/nrmicro3393); [3] NIH NIAID (https://www.niaid.nih.gov/research/antimicrobial-resistance); [4] PubChem (https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin-G); [5] WHO (https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance).

Other names

Pathogen-associated molecular patternsMicrobial componentsBacterial targetsViral targetsFungal targetsAntimicrobial targets

Inhibition of cell wall synthesis, inhibition of protein synthesis (30S/50S subunits), inhibition of nucleic acid synthesis (DNA gyrase/RNA polymerase), disruption of membrane integrity, and inhibition of viral replication enzymes.